Inflammation: The Major Player in Metabolic Syndrome
A special issue of Cells (ISSN 2073-4409).
Deadline for manuscript submissions: closed (20 October 2024) | Viewed by 1732
Special Issue Editor
2. Division of Endocrinology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA 15224, USA
Interests: glucose and lipid metabolism and metabolic disorders; inflammasomes; energy metabolism; glucose homeostasis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Metabolic disorders, including obesity, type 2 diabetes mellitus (T2DM), cardiovascular diseases, and fatty liver disease, are leading causes for preventable death in the U.S. and worldwide, and are a huge healthcare burden in terms of economics, quality of life, and morbidity/mortality. Inflammation has become one of the hottest research areas in the field of metabolic disorders in recent years. Inflammasomes are part of the innate immune system. They are intracellular oligomers that act as receptors and sensors that regulate the production of interleukin (IL)-1β and IL-18 in response to infectious microbes or molecules.
Recent research has demonstrated that inflammasomes are also involved in the regulation of energy metabolism and whole-body glucose homeostasis, indicating that inflammasomal proteins could be novel targets for treating metabolic disorders. Thus, this Special Issue aims to highlight recent advances in our understanding of the role of inflammasomes in energy metabolism, glucose homeostasis, and underlying molecular mechanisms. We invite you to submit your original research articles as well as review articles to facilitate the understanding of this newer field.
Dr. Zhenwei Gong
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inflammasomes
- energy metaboism
- metabolic syndrome
- chronic inflammation
- cytokine production
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
